Molecular Associations and Clinical Significance of Raps In
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Leukemia (2010) 24, 756–764 & 2010 Macmillan Publishers Limited All rights reserved 0887-6924/10 $32.00 www.nature.com/leu ORIGINAL ARTICLE Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells A Pellagatti1, M Cazzola2, A Giagounidis3, J Perry1, L Malcovati2, MG Della Porta2,MJa¨dersten4, S Killick5, A Verma6, CJ Norbury7, E Hellstro¨m-Lindberg4, JS Wainscoat1 and J Boultwood1 1LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, UK; 2Department of Hematology Oncology, University of Pavia Medical School, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 3Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany; 4Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK; 6Albert Einstein College of Medicine, Bronx, NY, USA and 7Sir William Dunn School of Pathology, University of Oxford, Oxford, UK To gain insight into the molecular pathogenesis of the the World Health Organization.6,7 Patients with refractory myelodysplastic syndromes (MDS), we performed global gene anemia (RA) with or without ringed sideroblasts, according to expression profiling and pathway analysis on the hemato- poietic stem cells (HSC) of 183 MDS patients as compared with the the French–American–British classification, were subdivided HSC of 17 healthy controls. The most significantly deregulated based on the presence or absence of multilineage dysplasia. In pathways in MDS include interferon signaling, thrombopoietin addition, patients with RA with excess blasts (RAEB) were signaling and the Wnt pathways. Among the most signifi- subdivided into two categories, RAEB1 and RAEB2, based on the cantly deregulated gene pathways in early MDS are immuno- percentage of bone marrow blasts. -
S41467-020-18249-3.Pdf
ARTICLE https://doi.org/10.1038/s41467-020-18249-3 OPEN Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain Lei Zhao1,2,17, Zhongqi Li 1,2,17, Joaquim S. L. Vong2,3,17, Xinyi Chen1,2, Hei-Ming Lai1,2,4,5,6, Leo Y. C. Yan1,2, Junzhe Huang1,2, Samuel K. H. Sy1,2,7, Xiaoyu Tian 8, Yu Huang 8, Ho Yin Edwin Chan5,9, Hon-Cheong So6,8, ✉ ✉ Wai-Lung Ng 10, Yamei Tang11, Wei-Jye Lin12,13, Vincent C. T. Mok1,5,6,14,15 &HoKo 1,2,4,5,6,8,14,16 1234567890():,; The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovas- cular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation- dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which pro- minently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed tran- scriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible. -
Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement. -
Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons
Published OnlineFirst August 12, 2013; DOI: 10.1158/0008-5472.CAN-13-0186 Cancer Tumor and Stem Cell Biology Research Double Minute Chromosomes in Glioblastoma Multiforme Are Revealed by Precise Reconstruction of Oncogenic Amplicons J. Zachary Sanborn1,2,Sofie R. Salama2,3, Mia Grifford2, Cameron W. Brennan4, Tom Mikkelsen6, Suresh Jhanwar5, Sol Katzman2, Lynda Chin7, and David Haussler2,3 Abstract DNA sequencing offers a powerful tool in oncology based on the precise definition of structural rearrange- ments and copy number in tumor genomes. Here, we describe the development of methods to compute copy number and detect structural variants to locally reconstruct highly rearranged regions of the tumor genome with high precision from standard, short-read, paired-end sequencing datasets. We find that circular assemblies are the most parsimonious explanation for a set of highly amplified tumor regions in a subset of glioblastoma multiforme samples sequenced by The Cancer Genome Atlas (TCGA) consortium, revealing evidence for double minute chromosomes in these tumors. Further, we find that some samples harbor multiple circular amplicons and, in some cases, further rearrangements occurred after the initial amplicon-generating event. Fluorescence in situ hybridization analysis offered an initial confirmation of the presence of double minute chromosomes. Gene content in these assemblies helps identify likely driver oncogenes for these amplicons. RNA-seq data available for one double minute chromosome offered additional support for our local tumor genome assemblies, and identified the birth of a novel exon made possible through rearranged sequences present in the double minute chromosomes. Our method was also useful for analysis of a larger set of glioblastoma multiforme tumors for which exome sequencing data are available, finding evidence for oncogenic double minute chromosomes in more than 20% of clinical specimens examined, a frequency consistent with previous estimates. -
Role and Regulation of the P53-Homolog P73 in the Transformation of Normal Human Fibroblasts
Role and regulation of the p53-homolog p73 in the transformation of normal human fibroblasts Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Lars Hofmann aus Aschaffenburg Würzburg 2007 Eingereicht am Mitglieder der Promotionskommission: Vorsitzender: Prof. Dr. Dr. Martin J. Müller Gutachter: Prof. Dr. Michael P. Schön Gutachter : Prof. Dr. Georg Krohne Tag des Promotionskolloquiums: Doktorurkunde ausgehändigt am Erklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbständig angefertigt und keine anderen als die angegebenen Hilfsmittel und Quellen verwendet habe. Diese Arbeit wurde weder in gleicher noch in ähnlicher Form in einem anderen Prüfungsverfahren vorgelegt. Ich habe früher, außer den mit dem Zulassungsgesuch urkundlichen Graden, keine weiteren akademischen Grade erworben und zu erwerben gesucht. Würzburg, Lars Hofmann Content SUMMARY ................................................................................................................ IV ZUSAMMENFASSUNG ............................................................................................. V 1. INTRODUCTION ................................................................................................. 1 1.1. Molecular basics of cancer .......................................................................................... 1 1.2. Early research on tumorigenesis ................................................................................. 3 1.3. Developing -
'Hrap1b-Retro: a Novel Human Processed Rap1b Gene
Letters to the Editor 146 Figure 1 The hRap1B-retro gene is localized on chromosome 5 q13.3. Upper part: summary of differences in the sequence alignment between hRap1B-retro and hRap1B cDNAs and the corresponding genomic regions on the 5th and 12th chromosomes. In addition to the three nucleotide substitutions in the open reading frame (ORF), seven more differences between both genes are present in the untranslated regions (UTRs). The coordinates above the sequences are relative to the start codon ATG in hRap1B cDNA (GI: 58219793). hRap1B-r_Ram1-3: full-length cDNAs of hRap1B-retro from Ramos cell line (GIs: 50475494, 50474682, 50470789); hRap1B-r_Neur: full-length cDNA of hRap1B-retro from neuroblastoma (GI: 50498405); hRap1B-r_Plac: full-length cDNA of hRap1B-retro from placenta (GI: 50492447). 5chr: genomic DNA sequence from chromosome 5 (GI: 51465008: 26064529–26060269), 12chr: genomic DNA sequence from chromosome 12 (GI: 29803948: 31147958– 31197631). Lower part: exonic structure of the hRap1B-retro and hRap1B mother genes mapped onto their cDNAs. Numbering stands for exon numbers. shown to transform NIH 3T3 cells oncogenically.2 In this light, a 4Department of Physiological Chemistry and the Centre for better expression profiling of the hRap1B-retro gene identified Biomedical Genetics, University Medical Centre Utrecht, by us will help to validate whether it defines a novel drug target. CG Utrecht, The Netherlands E-mail: [email protected] Acknowledgements TZ thanks Professor Martin Vingron for the helpful discussions and References support. TZ acknowledges support received from the BioSapiens Network of Excellence, funded by the European Commission 1 Gyan E, Frew M, Bowen D, Beldjord C, Preudhomme C, Lacombe C within its FP6 Programme, under the thematic area ‘Life sciences, et al. -
Hrap1b-Retro: a Novel Human Processed Rap1b Gene Blurs the Picture?
Letters to the Editor 145 human and mouse P-gp efflux capacity for imatinib, it is clear 2 Rumpold H, Wolf AM, Gruenewald K, Gastl G, Gunsilius E, Wolf D. that imatinib is an in vivo substrate for mouse P-gp.7,8 RNAi-mediated knockdown of P-glycoprotein using a transposon- We believe the differences in imatinib resistance seen when based vector system durably restores imatinib sensitivity in imatinib- comparing the K562 data by Rumpold et al. with our data in resistant CML cell lines. Exp Hematol 2005; 33: 767–775. 3 Zong Y, Zhou S, Sorrentino BP. Loss of P-glycoprotein expression in P-gp null mice is best explained by the possibility that CML stem hematopoietic stem cells does not improve responses to imatinib in cells express other ABC transporters that may provide a a murine model of chronic myelogenous leukemia. Leukemia 2005; redundant efflux mechanism for imatinib. The lack of expression 19: 1590–1596. of these compensatory transporters in K562 cells could therefore 4 Ferrao PT, Frost MJ, Siah SP, Ashman LK. Overexpression of explain the sensitizing effect of decreased expression of P-gp in P-glycoprotein in K562 cells does not confer resistance to the K562 cells. For instance, we have shown that K562 cells do not growth inhibitory effects of imatinib (STI571) in vitro. Blood 2003; 102: 4499–4503. express ABCG2 (unpublished data) while primary hematopoietic 5 Lange T, Gunther C, Kohler T, Krahl R, Musiol S, Leiblein S et al. 9 stem cells express significant levels. Therefore, we stand by our High levels of BAX, low levels of MRP-1, and high platelets are conclusion that the use of selective P-gp inhibitors to sensitize independent predictors of response to imatinib in myeloid blast CML stem cells to imatinib is not likely to be clinically useful. -
Structural Analysis of Autoinhibition in the Ras-Specific Exchange Factor
RESEARCH ARTICLE elife.elifesciences.org Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1 Jeffrey S Iwig1,2, Yvonne Vercoulen3†, Rahul Das1,2†, Tiago Barros1,2,4, Andre Limnander3, Yan Che1,2, Jeffrey G Pelton2, David E Wemmer2,5,6, Jeroen P Roose3*, John Kuriyan1,2,4,5,6* 1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States; 2California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, United States; 3Department of Anatomy, University of California, San Francisco, San Francisco, United States; 4Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States; 5Department of Chemistry, University of California, Berkeley, Berkeley, United States; 6Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, United States Abstract RasGRP1 and SOS are Ras-specific nucleotide exchange factors that have distinct roles in lymphocyte development. RasGRP1 is important in some cancers and autoimmune diseases but, in contrast to SOS, its regulatory mechanisms are poorly understood. Activating signals lead to the membrane recruitment of RasGRP1 and Ras engagement, but it is unclear how interactions between RasGRP1 and Ras are suppressed in the absence of such signals. We present a crystal structure of a fragment of RasGRP1 in which the Ras-binding site is blocked by an interdomain linker and the membrane-interaction surface of RasGRP1 is hidden within a dimerization interface that may be stabilized by the C-terminal oligomerization domain. NMR data demonstrate that calcium binding to the regulatory module generates substantial conformational changes that are incompatible with the inactive assembly. These features allow RasGRP1 to be maintained in an inactive state that is poised for activation by calcium and membrane-localization signals. -
Bioanalytical and Proteomic Approaches in the Study of Pathologic Ecs Dysfunctionality, Oxidative Stress and the Effects of PFKFB3 Modulators
Bioanalytical and proteomic approaches in the study of pathologic ECs dysfunctionality, oxidative stress and the effects of PFKFB3 modulators Sarath Babu Nukala ADVERTIMENT. La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió d’aquesta tesi per mitjà del servei TDX (www.tdx.cat) i a través del Dipòsit Digital de la UB (diposit.ub.edu) ha estat autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en activitats d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposició des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB. No s’autoritza la presentació del seu contingut en una finestra o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora. ADVERTENCIA. La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La difusión de esta tesis por medio del servicio TDR (www.tdx.cat) y a través del Repositorio Digital de la UB (diposit.ub.edu) ha sido autorizada por los titulares de los derechos de propiedad intelectual únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro ni su difusión y puesta a disposición desde un sitio ajeno al servicio TDR o al Repositorio Digital de la UB. -
Genome-Wide Association Study of Brain Amyloid Deposition As Measured by Pittsburgh Compound-B (Pib)-PET Imaging
Molecular Psychiatry (2021) 26:309–321 https://doi.org/10.1038/s41380-018-0246-7 ARTICLE Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging 1,2 3,4 5 1 3,4 1 Qi Yan ● Kwangsik Nho ● Jorge L. Del-Aguila ● Xingbin Wang ● Shannon L. Risacher ● Kang-Hsien Fan ● 6,7 8 7,9 6,7,8 1 Beth E. Snitz ● Howard J. Aizenstein ● Chester A. Mathis ● Oscar L. Lopez ● F. Yesim Demirci ● 1 6,7,8 3,4 Eleanor Feingold ● William E. Klunk ● Andrew J. Saykin ● for the Alzheimer’s Disease Neuroimaging 5 1,7,8 Initiative (ADNI) ● Carlos Cruchaga ● M. Ilyas Kamboh Received: 1 December 2017 / Accepted: 31 July 2018 / Published online: 25 October 2018 © The Author(s) 2018. This article is published with open access Abstract Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer’s disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI 11 1234567890();,: 1234567890();,: using C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant (P-meta = 9.09E-30; β = 0.18). -
New Secreted Toxins and Immunity Proteins Encoded Within the Type VI Secretion System Gene Cluster of Serratia Marcescens
Molecular Microbiology (2012) 86(4), 921–936 doi:10.1111/mmi.12028 First published online 27 September 2012 New secreted toxins and immunity proteins encoded within the Type VI secretion system gene cluster of Serratia marcescens Grant English,1† Katharina Trunk,1† into how pathogens utilize antibacterial T6SSs to Vincenzo A. Rao,2 Velupillai Srikannathasan,2 overcome competitors and succeed in polymicrobial William N. Hunter2 and Sarah J. Coulthurst1* niches. 1Division of Molecular Microbiology, College of Life Sciences, University of Dundee, Dundee, UK. 2Division of Biological Chemistry and Drug Discovery, Introduction College of Life Sciences, University of Dundee, Dundee, Protein secretion systems and their substrates are central UK. to bacterial virulence and interaction with other organisms (Gerlach and Hensel, 2007). Six different secretion Summary systems (Types I–VI) are used by Gram-negative bacteria to transport specific proteins to the exterior of the bacterial Protein secretion systems are critical to bacterial viru- cell or further inject them into target cells. The most lence and interactions with other organisms. The Type recently described of these is the Type VI secretion VI secretion system (T6SS) is found in many bacterial system (T6SS) (Filloux et al., 2008). T6SSs are complex species and is used to target either eukaryotic cells or multi-protein assemblies that span both bacterial mem- competitor bacteria. However, T6SS-secreted proteins branes and inject effector proteins directly from the bac- have proven surprisingly elusive. Here, we identified terial cytoplasm into target cells (Bonemann et al., 2010; two secreted substrates of the antibacterial T6SS from Cascales and Cambillau, 2012). T6SSs are encoded by the opportunistic human pathogen, Serratia marces- large, variable gene clusters that contain 13 ‘core’ essen- cens. -
Rap1b Facilitates NK Cell Functions Via IQGAP1-Mediated Signalosomes
Article Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes Aradhana Awasthi,1 Asanga Samarakoon,1 Haiyan Chu,1 Rajasekaran Kamalakannan,1 Lawrence A. Quilliam,5 Magdalena Chrzanowska-Wodnicka,3 Gilbert C. White II,2 and Subramaniam Malarkannan1,4 1Molecular Immunology, 2Platelet, and 3Vascular Signaling, Blood Research Institute, 4Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226 5Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202 Downloaded from https://rupress.org/jem/article-pdf/207/9/1923/536670/jem_20100040.pdf by guest on 13 May 2020 Rap1 GTPases control immune synapse formation and signaling in lymphocytes. However, the precise molecular mechanism by which Rap1 regulates natural killer (NK) cell activa- tion is not known. Using Rap1a or Rap1b knockout mice, we identify Rap1b as the major isoform in NK cells. Its absence significantly impaired LFA1 polarization, spreading, and microtubule organizing center (MTOC) formation in NK cells. Neither Rap1 isoform was essential for NK cytotoxicity. However, absence of Rap1b impaired NKG2D, Ly49D, and NCR1-mediated cytokine and chemokine production. Upon activation, Rap1b colocalized with the scaffolding protein IQGAP1. This interaction facilitated sequential phosphorylation of B-Raf, C-Raf, and ERK1/2 and helped IQGAP1 to form a large signalosome in the peri- nuclear region. These results reveal a previously unrecognized role for Rap1b in NK cell signaling and effector functions. CORRESPONDENCE The Ras-mediated Raf–MEK–ERK activation Paxillin can function as signal processing cen- Subramaniam Malarkannan: pathway controls many fundamental cellular ters by bringing together GTPases, kinases, and [email protected] processes. Rap1 belongs to the Ras superfamily, their substrates (Sacks, 2006).